Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo

NeuroSignals

Volumn 9, Issue 3-4, 2000, Pages 160-171

  J Reiter, Russel ^a   Tan, Dun Xian ^a   Qi, Wenbo ^a   Manchester, Lucien C ^a   Karbownik, Malgorzata ^a   Calvo, Juan R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antioxidant; Cancer; Free radicals; Ischemia reperfusion injury; Melatonin; Neurogeneration

Indexed keywords

MELATONIN;

ANTIOXIDANT ACTIVITY; CANCER INHIBITION; CONFERENCE PAPER; HEART INFARCTION; ISCHEMIA; NERVE DEGENERATION; OXIDATIVE STRESS; PINEAL BODY; REPERFUSION INJURY; STROKE; TISSUE DISTRIBUTION;

AGING; ANIMALS; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; FREE RADICAL SCAVENGERS; HUMANS; MELATONIN; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 0033925920     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014636     Document Type: Article

References (86)

1. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ: Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr J 1993;1:57-60.
2. Reiter RJ, Oh CS, Fujimori O: Melatonin: Its intracellular and genomic actions. Trends Endocrinol Metab 1996;7:22-26.
3. Reiter RJ, Tan DX, Qi W: Suppression of oxygen toxicity by melatonin. Acta Pharmacol Sin 1998; 19: 575-581.
4. Reiter RJ: Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 1998; 56:359-384.
5. Reiter RJ, Tan DX, Cabrera J, D’arpa D, Sainz RM, Mayo JC, Ramos S: The oxidant/antioxidant network: Role of melatonin. Biol Signals Recept 1999;8:56-63.
6. Tan DX, Reiter RJ, Chen LD, Poeg-geler B, Manchester LC, Barlow-Walden LR: Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 1994;15:215-218.
7. Manev H, Uz T, Kharlamov A, Joo JY: Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J 1996;10:1546-1551.
8. Reiter RJ, Tan DX, Kim SJ, Manchester LC, Qi W, Garcia JJ, Cabrera JC, El-Sokkary G, Rouvier-Garay V: Augmentation of indices of oxidative damage in life-long melatonin-deficient rats. Mech Aging Dev 1999;110:157-173.
9. Stasica P, Ulanski P, Rosiak JM: Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998;25:65-66.
10. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Wein-traub ST, Vijayalaxmi Shepherd AMM: A novel melatonin metabolite, cyclic 3-hydroxymelatonin: A biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998;253:614-620.
11. Mahal HS, Sharma HS, Mukerjee T: Antioxidant properties of melatonin: A pulse radiolysis study. Free Radic Biol Med 1999;26:557-565.
12. Pahkla R, Zilmer M, Kullisar M, Rago L: Comparison of the antioxidant activity of melatonin and pi-noline in vivo. J Pineal Res 1998;24: 96-101.
13. Tan DX, Manchester LC, Reiter RJ, Plummer BF: Cyclic 3-hydroxy-melatonin: A melatonin metabolite generated as a result of hydroxyl radical scavenging. Biol Signals Re-cept 1999;8:70-74.
14. Tan DX, Manchester LC, Reiter RJ, Qi WB, Karbownik M, Calvo JR: Significance of melatonin in antioxidative defense system: Reactions and products. Biol Signals Recept 2000;9:137-159.
15. Zang LY, Cosma G, Gardner H, Vallynathan V: Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998; 1425: 469-477.
16. Noda Y, Mori A, Liburty R, Packer L: Melatonin and its precursors scavenge nitric oxide. J Pineal Res 1999;27:159-163.
17. Zhang H, Squadrito GL, Pryor WA: Reaction of peroxynitrite with melatonin: A mechanistic study. Chem Res Toxicol 1999;12:526-534.
18. Pablos MI, Guerrero JM, Ortiz GG, Agapito MT, Reiter RJ: Both melatonin and a putative nuclear receptor agonist CGP 52608 stimulate glutathione peroxidase and glutathione reductase activities in mouse brain in vivo. Neuroendocrinol Lett 1997;18:49-58.
19. Reiter RJ, Tang L, Garcia JJ, Mu-noz-Hoyos A: Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci 1997;60: 2255-2271.
20. Hara M, Iigo M, Ohtani-Kaneko R, Nakamura N, Suzuki T, Reiter RJ, Hirata K: Administration of melatonin and related indoles prevents exercise-induced cellular oxidative changes in rats. Biol Signals 1997;6: 90-100.
21. Garcia JJ, Reiter RJ, Guerrero JM, Escames G, Yu B, Oh CS, Munoz-Hoyos A: Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997;408:297-300.
22. Garcia JJ, Reiter RJ, Ortiz GG, Oh CS, Tang L, Yu BP, Escames G: Melatonin enhances tamoxifen’s ability to prevent the reduction in microsomal membrane fluidity induced by lipid peroxidation. J Membr Biol 1998;162:59-65.
23. Menendez-Pelaez A, Reiter RJ: Distribution of melatonin in mammalian tissues: Relative importance of nuclear verses cytosolic localization. J Pineal Res 1993;15:59-69.
24. Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden LR, Pablos MI, Tan DX: Nuclear localization of melatonin in different mammalian tissues: Immunocytochemi-cal and radioimmunoassay evidence. J Cell Biochem 1993;53:572-582.
25. Troiani ME, Reiter RJ, Tannen-baum MG, Puig-Domingo M, Guerrero JM, Menendez-Pelaez A: Neither the pituitary gland nor the sympathetic nervous system is responsible for eliciting the large drop in elevated rat pineal melatonin levels due to swimming. J Neural Transm 1988;74:149-160.
26. Pohjanvirta R, Laitinen JT, Vakkuri O, Linden J, Kokkola T, Unkila M, Tuomisto J: Mechanism by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces circulating melatonin levels in the rat. Toxicology 1996;107:85-97.
27. Conti A, Conconi S, Hertens E, Skwarlo-Sonta K, Markowska M, Maestroni GJM: Evidence for melatonin synthesis in mouse and human bone marrow cells. J Pineal Res, in press.
28. Tan DX, Manchester LC, Reiter RJ, Qi W, Zhang M, Weintraub ST, Cabrera J, Sainz RM, Mayo JC: Identification of highly elevated levels of melatonin in bone marrow: Its origin and significance. Biochim Bio-phys Acta 1999;1472:206-214.
29. Tan DX, Manchester LC, Reiter RJ, Qi W, Hanes MA, Farley NJ: High physiological levels of melatonin in the bile of mammals. Life Sci 1999; 65:2523-2529.
30. Skinner DC, Malpaux B: High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999;140:4399-4405.
31. Antolin I, Obst B, Burkhardt S, Har-deland R: Antioxidative protection in a high-melatonin organism: The dinoflagellate Gonyaulax polyedra is rescued from lethal stress by strongly elevated, but physiologically possible concentrations of melatonin. J Pineal Res 1997;23:182-190.
32. Urata Y, Honma S, Goto S, Todoro-ki S, Iida T, Cho S, Honma K, Kon-do T: Melatonin induces y-glutamyl-cysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radic Biol Med 1999;27:838-847.
33. Pang SF, Allen AE: Extra-pineal melatonin in the retina: Its regulation and physiological function; in Reiter RJ (ed): Pineal Research Reviews. New York, Liss, 1986, vol IV, pp 55-95.
34. Ebihara S, Adachi A, Hasegawa M, Nogi T, Yoshimura T, Hirunagi K: In vivo microdialysis studies of pineal and ocular melatonin rhythms in birds. Biol Signals 1997;6:233-240.
35. Marchiafava PL, Longoni B: Melatonin as an antioxidant in retinal photoreceptor cells. J Pineal Res 1999;26:184-189.
36. Costa EJX, Lopes RH, Lamy-Freund MT: Permeability of pure lipid bilayers to melatonin. J Pineal Res 1995;19:123-124.
37. Shida CS, Castrucci AML, Lamy-Freund MT: High melatonin solubility in aqueous medium. J Pineal Res 1994;161:198-201.
38. Tang PL, Xu MF, Qian ZM: Differential behaviour of cell membranes towards iron-induced oxidative damage and the effects of melatonin. Biol Signals 1997;6:291-300.
39. Carneiro RCG, Reiter RJ: 8-Amino-levulenic acid-induced lipid peroxidation in rat kidney and liver is attenuated by melatonin: An in vitro and in vivo study. J Pineal Res 1998;24:131-136.
40. Alarcondela Lastra A, Motilva V, Martin MJ, Nieto A, Barranco MD, Cabeza J, Herrerias JM: Protective effect of melatonin on indometha-cin-induced gastric injury in rats. J Pineal Res 1999;26:101-107.
41. Morishima I, Okumura K, Matsui H, Kaneko S, Dumaguchi Y, Kawa-kami K, Makuno S, Hayakawa M, Toki Y, Ito T, Hayakawa T: Zinc accumulation in Adriamycin-in-duced cardiomyopathy in rats: Effects of melatonin, a cardioprotective antioxidant. J Pineal Res 1999; 26:204-210.
42. Tang L, Reiter RJ, Li ZR, Ortiz GG, Yu BP, Garcia JJ: Melatonin reduces the increase in 8-hydroxy-deoxyguanosine levels in the brain and liver of kainic acid-treated rats. Mol Cell Biochem 1998; 178:299-303.
43. Wakatsuki A, Okatani Y, Izumiya C, Ikenoue N: Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain. J Pineal Res 1999;26:147-152.
44. Vijayalaxmi, Meltz ML, Reiter RJ, Herman TS: Melatonin and protection from genetic damage in blood and bone marrow: Whole-body irradiation studies in mice. J Pineal Res 1999;27:221-225.
45. Cuzzocrea S, Caputi AP: Protective effect of melatonin on zymosan-induced cellular damage. Biol Signals Recept 1999;8:136-142.
46. Sun EY, Lin X, Zhang LM, Lu SD, Pan S: Effects of melatonin on DNA damage and repair in rat brain following a transient cerebral ischemia (abstract). Biol Signals Recept 2000; 9:69.
47. Tesoriere L, D’arpa D, Conti S, Giaccone V, Pinaudi AM, Livrea MA: Melatonin protects human red blood cells from oxidative hemolysis: New insights into the radicalscavenging activity. J Pineal Res 1999;27:95-105.
48. Ceraulo L, Ferrugia M, Tesoriere L, Segreto S, Livrea MA, Turco Livrea V: Interactions of melatonin with membrane models: Portioning of melatonin in AOT and lecithin reversed micelles. J Pineal Res 1999; 26:108-112.
49. Kotler M, Rodriquez C, Sainz RM, Antolin I, Menendez-Pelaez A: Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998;24:83-89.
50. El-Sokkary GH, Reiter RJ, Tan DX, Kim SJ, Cabrera J: Inhibitory effect of melatonin on products of lipid peroxidation resulting from chronic ethanol administration. Alcohol Alcohol 1999;34:842-850.
51. Okatani Y, Okamoto K, Hayashi K, Wakatsuki A, Tamura S, Sagara Y: Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 1998;25:129-134.
52. Benot S, Goberna R, Reiter RJ, Gar-cia-Maurino S, Osuna C, Guerrero JM: Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res 1999;27:59-64.
53. Benot S, Molinero P, Soutto M, Go-berna R, Guerrero JM: Circadian variations in the rat serum total antioxidant status: Correlation with melatonin levels. J Pineal Res 1998; 25:1-4.
54. Richardson JS, Zhou Y: Oxidative stress in the production and expression of neurotoxic P-amyloid. Rest Neurol Neurosci 1996;9:207-211.
55. Reiter RJ, Garcia JJ, Pie J: Oxidative toxicity in models of neurodegeneration: Responses to melatonin. Rest Neurol Neurosci 1998; 12:135-142.
56. Pappolla MA, Chyan YJ, Poeggeler B, Frangione B, Wilson G, Ghiso J, Reiter RJ: An assessment of the antioxidant and antiamyloidogenic properties of melatonin: Implications for Alzheimer’s disease. J Neural Transm, in press.
57. Ames BN, Shigenaga MK: Oxidants are a major contributor to cancer and aging; in Halliwell B, Aruoma-OI (eds): DNA and Free Radicals. London, Harwood, 1993, pp 1-18.
58. Reiter RJ: Oxidative damage to nuclear DNA: Amelioration by melatonin: Neuroendocrinol Lett 1999; 20:145-150.
59. Janeiro DR: Ischemic heart disease and antioxidants: Mechanistic aspects of oxidative injury and its prevention. Crit Rev Food Sci Nutr 1995;35:65-81.
60. Globus MY, Busto R, Lin B, Schnip-pering H, Ginsberg MD: Detection of free radical activity during transient global ischemia and recirculation: Effects of intraischemic brain temperature modulation. J Neuro-chem 1995;65:1250-1256.
61. Harman D: The aging process: Major risk factor for disease and death. Proc Natl Acad Sci USA 1991;88: 5360-5363.
62. Reiter RJ: Aging and oxygen toxicity: Relation to changes in melatonin. Age 1997;20:201-213.
63. Markesbury WR: Oxidative stress hypothesis of Alzheimer’s disease. Free Radic Biol Med 1997;23:134-137.
64. Yoshikawa T: Free radicals and their scavengers in Parkinson’s disease. Eur Neurol 1993;33(suppl 1): 60-68.
65. Heyes MP: The kynurenine pathway and neurological disease. Therapeutic strategies. Adv Exp Med Biol 1996;398:125-129.
66. Pappolla MA, Sos M, Beck RJ, Hickson Bick DML, Reiter RJ, Ethimiopoules S, Robakis NK: Melatonin prevents death of neuroblastoma cells exposed to Alzheimer amyloid peptide. J Neurosci 1997; 17:1683-1690.
67. Pappolla MA, Bozner P, Sos C, Chao H, Robakis NK, Zagorski M, Frangione B, Ghiso J: Inhibition of Alzheimer’s P-fibrillogenesis by melatonin. J Biol Chem 1998;273: 185-188.
68. Brusco LI, Marquez M, Cardinali DP: Monozygotic twins with Alzheimer’s disease treated with melatonin. Case report. J Pineal Res 1998;25:260-263.
69. Acuna-Castroviejo D, Coto-Montes A, Monti MG, Ortiz GG, Reiter RJ: Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sci 1997;60: PL23-PL29.
70. Iacovitti L, Stull ND, Johnston K: Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress. Brain Res 1997;768:317-326.
71. Mayo JC, Sainz R, Uria H, Antolin I, Esteban MM, Rodriquez C: Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells. Implications for Parkinson’s disease. J Pineal Res 1998;24:179-192.
72. Southgate GS, Daya S, Potgieter B: Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus. J Chem Neuroanat 1998;14:151-156.
73. Cabrera J, Reiter RJ, Tan DX, Qi W, Sainz RM, Mayo JC, Carcia JJ, Kim SJ, El-Sokkary GH: Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitro and in vivo findings. Neuropharmacology 2000;39:507-514.
74. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 1999;59:4693-4701.
75. Qi W, Reiter RJ, Tan DX, Manchester LC, Siu AW, Garcia JJ: Increased levels of oxidatively damaged DNA induced by chromi-um(III) and H2O2: Protection by melatonin and related molecules. J Pineal Res, in press.
76. Vijayalaxmi, Reiter RJ, Herman TS, Meltz ML: Melatonin and radioprotection from genetic damage: In vivo/in vitro studies with cells from human volunteers. Mutat Res 1996;371:221-228.
77. Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ, El-Sokkary GH: Isch-emia/reperfusion-induced arrhythmias in isolated rat heart: Prevention by melatonin. J Pineal Res 1998;25:184-191.
78. Guerrero JM, Reiter RJ, Ortiz GG, Pablos MI, Sewerynek E, Chuang JI: Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones ungui-culatus). J Pineal Res 1997;23:24-31.
79. Kilic E, Ozdemir YG, Bolay H, Kel-estimur H, Dalkara T: Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia. J Cerebr Blood Flow Metab 1999;19:511-518.
80. Pei Z, Pang SF, Cheung RTF: Melatonin protects against focal cerebral ischaemia in the rat (abstract). Biol Signals Recept 2000;9:65.
81. Sewerynek E, Reiter RJ, Melchiorri D, Ortiz GG, Lewinski A: Oxidative damage in the liver induced by ischemia-reperfusion. Protection by melatonin. Hepatogastroenterology 1996;43:898-905.
82. Cuzzocrea S, Costantino G, Mazzon E, Micali A, De Sarro A, Caputi AP: Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion. J Pineal Res 2000;28:52-63.
83. Martin M, Macias M, Escames G, Reiter RJ, Agapito MT, Ortiz GG, Acuna-Castroviejo D: Melatonin-induced increased activity of the respiratory chain complex I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res, in press.
84. Reiter RJ: The aging pineal and its physiological consequences. Bioessays 1992;14:169-175.
85. Hardeland R: New actions of melatonin and their relevance to biometeorology. Int J Biometeorol 1997; 41:47-57.
86. Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C: Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Res 1999;50:271-279.